$2.14 Billion is the total value of CADIAN CAPITAL MANAGEMENT, LP's 42 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CMCSA | New | COMCAST CORP NEWcl a | $56,527,000 | – | 1,469,000 | +100.0% | 2.64% | – |
| TRVG | New | TRIVAGO N V | $31,090,000 | – | 2,865,427 | +100.0% | 1.46% | – |
| EVH | New | EVOLENT HEALTH INCcl a | $16,732,000 | – | 940,000 | +100.0% | 0.78% | – |
| TSRO | New | TESARO INC | $14,020,000 | – | 108,600 | +100.0% | 0.66% | – |
| NUVA | New | NUVASIVE INC | $10,815,000 | – | 195,000 | +100.0% | 0.51% | – |
| INCY | New | INCYTE CORP | $10,285,000 | – | 88,100 | +100.0% | 0.48% | – |
| CMCSA | New | COMCAST CORP NEWcall | $9,620,000 | – | 250,000 | +100.0% | 0.45% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $6,032,000 | – | 400,000 | +100.0% | 0.28% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $3,972,000 | – | 48,000 | +100.0% | 0.19% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $2,537,000 | – | 25,000 | +100.0% | 0.12% | – |
| AXGT | New | AXOVANT SCIENCES LTD | $1,720,000 | – | 250,000 | +100.0% | 0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RADWARE LTD | 34 | Q3 2021 | 4.9% |
| PALO ALTO NETWORKS INC | 32 | Q3 2023 | 18.5% |
| PEGASYSTEMS INC | 27 | Q3 2023 | 9.1% |
| ALPHABET INC | 27 | Q3 2023 | 9.0% |
| GENMARK DIAGNOSTICS INC | 27 | Q1 2020 | 2.3% |
| VARONIS SYS INC | 26 | Q3 2023 | 9.5% |
| IAC INTERACTIVECORP | 24 | Q2 2020 | 17.8% |
| ELECTRONICS FOR IMAGING INC | 24 | Q1 2019 | 8.8% |
| ZOGENIX INC | 23 | Q4 2021 | 7.1% |
| NANOSTRING TECHNOLOGIES INC | 22 | Q2 2023 | 2.5% |
View CADIAN CAPITAL MANAGEMENT, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| RADWARE LTDSold out | February 14, 2022 | 0 | 0.0% |
| TCV Acquisition Corp. | February 14, 2022 | 2,750,000 | 6.7% |
| WORLD WRESTLING ENTERTAINMENTINCSold out | February 14, 2022 | 0 | 0.0% |
| ZOGENIX, INC. | February 14, 2022 | 4,240,846 | 7.6% |
| GenMark Diagnostics, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NanoString Technologies IncSold out | February 12, 2021 | 0 | 0.0% |
| VARONIS SYSTEMS INC | February 12, 2021 | 1,017,422 | 3.2% |
| PORTOLA PHARMACEUTICALS INC | February 13, 2020 | 2,133,343 | 2.7% |
| ELECTRONICS FOR IMAGING INC | February 13, 2019 | 3,365,179 | 7.7% |
| trivago N.V.Sold out | February 13, 2019 | 0 | 0.0% |
View CADIAN CAPITAL MANAGEMENT, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View CADIAN CAPITAL MANAGEMENT, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.